Table 1.
Age and clinicopathological characteristics of patients.
| Non-metastatic (n = 25) |
Metastatic (n = 23) |
Test of sig. | P- value | |||
|---|---|---|---|---|---|---|
| No. | % | No. | % | |||
| Age (years) | ||||||
| Min. – Max. | 30.0–68.0 | 26.0–62.0 | t = 0.626 | 0.535 | ||
| Mean ± SD. | 47.96 ± 11.19 | 46.0 ± 10.45 | ||||
| Menstrual status | ||||||
| Post-menopause | 11 | 44.0 | 11 | 47.8 | c2= 0.071 |
0.790 |
| Pre-menopause | 14 | 56.0 | 12 | 52.2 | ||
| Histopathological subtypes | ||||||
| Invasive Ductal C | 24 | 96.0 | 22 | 95.7 | c2= 13.057 |
MCp= 0.001 |
| Mucoid cancer | 1 | 4.0 | 0 | 0.0 | ||
| Invasive lobular C | 0 | 0.0 | 1 | 4.3 | ||
| Tumor size (cm). | ||||||
| Min. – Max. | 2.0–8.0 | 1.50–10.0 | t= 1.166 |
0.250 | ||
| Mean ± SD. | 3.84 ± 1.81 | 4.55 ± 2.41 | ||||
| Total axillary lymph nodes | ||||||
| Min. – Max. | 4.0–31.0 | 8.0–26.0 | U= 158.50 |
0.422 | ||
| Median (IQR) | 13.0 | 14 | ||||
| Infiltrated axillary lymph nodes | ||||||
| Min. – Max. | 0.0–27.0 | 0.0–8.0 | U= 269.0 |
0.699 | ||
| Median (IQR) | 2.0 (0.0–2.0) | 3.0 (9.0–5.0) | ||||
| Histological Grade | ||||||
| II | 18 | 72.0 | 15 | 65.2 | c2= 0.257 |
0.613 |
| III | 7 | 28.0 | 8 | 34.8 | ||
| Clinical Stage | ||||||
| II | 12 | 48.0 | 0 | 0.0 | c2 = 48.0∗ | <0.001∗ |
| III | 13 | 52.0 | 0 | 0.0 | ||
| IV | 0 | 0.0 | 23 | 100.0 | ||
χ2: Chi square test MC: Monte Carlo U: Mann Whitney test t: Student t-test.